Research programme: gastrointestinal stromal tumour therapeutics - Clovis Oncology/Array BioPharmaAlternative Names: cKIT inhibitor - Clovis Oncology/Array BioPharma
Latest Information Update: 16 Jul 2016
At a glance
- Originator Array BioPharma; Clovis Oncology
- Class Small molecules
- Mechanism of Action Proto oncogene protein c-kit inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Gastrointestinal stromal tumours
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Gastrointestinal-stromal-tumours in USA (PO)
- 16 Jul 2012 Early research in Gastrointestinal stromal tumours in USA (PO)